What's New at Charles River
   
 
 
   
   

Expanded Non-GLP Rodent Pharmacokinetic Services Now Available

March 31, 2009 – In response to the growing demand for non-GLP pharmacokinetic (PK) studies, Charles River Discovery and Imaging Services has expanded its rodent PK offerings to better meet our customer’s needs. Quick study initiation and various dosing regimens and administration routes are combined with bioanalytical support for both small molecules and biologics to rapidly identify and optimize your potential drug candidates.

Whether you have only one compound or a library of compounds requiring drug metabolism assessment, Charles River can design, conduct, and interpret the in vivo PK/ADME components of your program as part of our streamlined non-GLP screening services. Our rapidly expanding portfolio now includes bile-duct cannulated rat ADME studies as well as continuous infusion of rats followed by blood sampling.

For more information on our PK capabilities, please click here.

   
Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
May 08 - Access Xenograft Data for Immunode...
May 01 - New GEMS Webinars Now Available On...
Jun 02-Jun 05 - Vancouver, British Columbia - CALAS
Jun 18-Jun 21 - Newton, MA - 2012 Charles River Short Course on Laboratory Animal Scien...
Jun 05-Jun 08 - Saint Germain sur l’Arbresle, France - Charles River LAL Seminar Series
view all
Scientist I Wilmington, MA
Manager International Tax Wilmington, MA

Charles River Laboratories, Inc.